Presentation

Study Modifications and Primary Endpoint Reinterpretations Prior to FDA Approval of High-Risk Cardiovascular Devices

Presenter: Sanket S. Dhruva

January 03, 2012

REGISTER for free or LOG IN to view this content

Study Modifications and Primary Endpoint Reinterpretations Prior to FDA Approval of High-Risk Cardiovascular Devices

Policy & Practice

Presentation

TCT 2012

Up Next

Presentation

Use Of Thrombectomy Devices In Primary Percutaneous Coronary Intervention.

Presenter: Neville Kukreja

January 03, 2012

More slides +

Presentation

In hospital and 30 day outcomes in all-comer percutaneous coronary intervention with bivalirudin: Initial report of the prospective EUROVISION Registry. Hamon M, Nienaber C,...

Presenter: Martial Hamon

January 03, 2012

Presentation

Copeptin: An Ultra Early Prognostic Marker for Acute Myocardial Infarction

Presenter: Ho Lam

January 03, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.